Premium
Retracted: Systematic review: benefits and harms of transarterial embolisation for treating hepatocellular adenoma
Author(s) -
Zhao C.,
Pei S. L.,
Cucchetti A.,
Tong T. J.,
Ma Y. L.,
Zhong J. H.,
Li L. Q.
Publication year - 2017
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.14044
Subject(s) - medicine , medline , hepatocellular adenoma , adenoma , medical physics , general surgery , political science , law
Transarterial embolisation (TAE) is a standard treatment for bleeding hepatocellular adenoma (HCA) and, occasionally, symptomatic HCA involving large tumours. Whether TAE is similarly safe and effective as an elective treatment for bleeding and nonbleeding HCA remains unclear.